COVID-19 patients with immune-mediated inflammatory diseases (IMIDs) may benefit from tumor necrosis factor (TNF) inhibitors, according to a study published yesterday in JAMA Network Open.
COVID-19 outpatients were more likely to have more respiratory symptoms if they were overweight or obese, according to a study published yesterday in Influenza and Other Respiratory Viruses.
COVID-19 vaccination does not increase the risk of miscarriage during the first trimester of pregnancy, according to a Norwegian case-control study that involved 13,956 women, 5.5% of whom were vaccinated against the virus. The results were published yesterday as a letter to the editor in the New England Journal of Medicine.
A review of antibiotic prescribing at Veterans' Health Administration (VHA) mental health units found that only 1 in 10 patients were exposed to antibiotics, but urinary tract infections (UTIs) appeared to be frequently misdiagnosed, researchers reported today in Infection Control & Hospital Epidemiology.
Two recent studies in Pediatrics look at risk factors for severe pediatric COVID-19 and COVID deaths in those younger than 21 years of age.
The Centers for Disease Control and Prevention (CDC) said today that lab tests have identified a rare, potentially deadly bacterium in an aromatherapy spray.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Oct 21
The Pan American Health Organization (PAHO) is calling for increased surveillance and investigation of carbapenemase-producing Enterobacterales in Latin America and the Caribbean.
First responders' risk for COVID-19 infection is about 60% more than other essential workers, including healthcare workers (HCWs), according to a study published late last week in JAMA Health Forum.
A guaranteed $25 cash card for both vaccine recipients and drivers of vaccine recipients lessened slowing COVID-19 vaccine uptake at participating sites in North Carolina, according to a research letter in JAMA Internal Medicine yesterday.
Positive pneumococcal urinary antigen testing (PUAT) results among patients hospitalized with community-acquired pneumonia (CAP) was associated with earlier time to de-escalation of antibiotics, according to a single-center study published last week in Open Forum Infectious Diseases.
COVID-mitigating behavior such as physical distancing and mask use didn't change after receipt of vaccination prior to government exemptions, according to a research letter published yesterday in JAMA Network Open.
Formula feeding is associated with a 70% increase in antibiotic resistance gene (ARG) abundance in the gut microbiome of infants compared with breast milk, US and Finnish researchers reported this week in the American Journal of Clinical Nutrition.
The monoclonal antibody sotrovimab reduced the risk of hospitalization or death from COVID-19 by 85% compared with placebo, according to an interim analysis of a phase 3 clinical trial published yesterday in the New England Journal of Medicine.
Use of a rapid diagnostic test in patients with bloodstream infections (BSIs) was associated with shorter times to optimal antibiotic therapy and antibiotic de-escalation, researchers reported yesterday in Clinical Infectious Diseases.
Cancer patients who received systemic treatment like chemotherapy or radiation in the 3 months before testing positive for COVID-19 were at increased risk of death, admission to an intensive care unit (ICU), and hospitalization, according to a study yesterday in JAMA Oncology.
Yesterday, the Centers for Disease Control and Prevention (CDC) added 1 case and 3 hospitalizations to a multistate Salmonella outbreak—now at 21 cases—tied to salami sticks sold at Trader Joe's and Wegmans, and earlier this week the agency declared its investigation into a Salmonella outbreak tied to Italian-style meats over after 40 cases in 17 states.
Originally published by CIDRAP News Oct 28
Antibiotic prescribing during the early COVID-19 months in Canada dropped sharply, according to two new studies, one that looked at retail pharmacy trends across the country and one that focused on outpatient prescribing patterns in Ontario.
A third Pfizer COVID-19 vaccine dose is 92% more effective in reducing severe COVID-related outcomes than two doses of the same vaccine received at least 5 months previously, according to a large real-world study late last week in The Lancet.
Among children with community-acquired pneumonia (CAP) who were discharged from the hospital within 48 hours but required further outpatient treatment, a lower dose of oral amoxicillin was non-inferior to a higher dose, and a 3-day duration was non-inferior to 7 days, according to the results of a randomized clinical trial published today in JAMA.
Two doses of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines were 93% and 96% effective, respectively, in preventing severe, critical, or fatal disease caused by the highly transmissible Delta (B1617.2) variant, a study today in Nature Medicine finds.
Spanish, Italian, and UK physicians reported high levels of depression and anxiety during the first two waves of the COVID-19 pandemic, finds a study yesterday in PLOS One.
The initial COVID-19 vaccine campaign in the United States was associated with fewer infections, emergency department (ED) visits, and hospitalizations among adults 65 and older, finds a study yesterday in The Lancet.
Most pregnant women with a reported history of penicillin allergy who were tested were found not to be allergic and could tolerate penicillin during labor, according to a small retrospective study presented today at the annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI).
